Course Description:

We cordially invite you to attend the 3rd World Bronchiectasis Conference at Georgetown University in Washington, DC on July 12-14, 2018. The conference is a focused, cutting-edge gathering of the world’s experts on bronchiectasis and nontuberculous mycobacterial lung infections. Highlights include recent advances in research on disease mechanisms in bronchiectasis, including new understandings on the role of inflammation, infection and the microbiome. Clinical topics will include sessions on the diagnosis and treatment of bronchiectasis and NTM infections, including small group, case-based presentations specifically aimed at understanding the role of airway clearance, anti-inflammatory treatments and antibiotics. On Saturday morning, July 14th, the program will navigate the management of patients with nontuberculous mycobacterial lung infections and will be of particular interest to pulmonologists and infectious disease practitioners who treat patients with these challenging infections.

The meeting brings together the expertise of the US Bronchiectasis Research Registry and the European Bronchiectasis Registry (EMBARC) principal investigators as well as experts from Canada, Asia, Australia and New Zealand. This program will benefit the entire healthcare team who care for patients with bronchiectasis and NTM infections including pulmonologists, infectious disease physicians, pharmacists, nurses and respiratory care practitioners.

Target Audience:

This conference is intended for pulmonologists, critical care physicians, infectious disease specialists, pharmacists, residents, fellows, nurse practitioners, physician assistants, nurses, respiratory care practitioners, allied health professionals, students, and any members of the healthcare team interested in the evaluation, diagnosis, and management of patients with bronchiectasis and nontuberculous mycobacterial lung infections.

Learning Objectives:

  • Recognize the prevalence of bronchiectasis and utilize strategies to diagnose and assess severity.
  • Implement appropriate treatments for bronchiectasis based on current guidelines and review of the literature.
  • Analyze the patient’s perspective with regards to the impact of the disease and treatment on day to day life.
  • Utilize best practices in treating specific infections in bronchiectasis.
  • Recognize the important role of respiratory care practitioners in teaching airway clearance modalities.
  • Identify the drug and patient-specific issues that complicate the care of patients requiring multiple therapies.


In support of improving patient care, MedStar Health is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), the American Nurses Credentialing Center (ANCC) and the American Academy of PAs (AAPA) to provide continuing education for the healthcare team.

Credit Designation:

This activity was planned by and for the healthcare team, and learners will receive 13.75 Interprofessional Continuing Education (IPCE) credits for learning and change.


For Respiratory Care Therapists
This activity has been approved for 12 Respiratory CEUs by the MD/DC Society for Respiratory Care.